Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...
A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.
The CRADA establishes a collaborative framework on medical countermeasures that protect global populations and U.S. soldiers ...
The FDA PreCheck Pilot Program will focus on manufacturing readiness, regulatory predictability, and expedited facility ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...
Researchers have developed new AI approach to select chemical compounds potentially effective for treating tuburculosis.
Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...
Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...
New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.
Novartis has agreed to acquire Myricx Bio, a London-based developer of next-generation antibody-drug conjugates (ADCs), for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results